Your browser doesn't support javascript.
loading
Tuberculosis-diabetes co-morbidity is characterized by heightened systemic levels of circulating angiogenic factors.
Kumar, Nathella Pavan; Moideen, Kadar; Sivakumar, Shanmugam; Menon, Pradeep A; Viswanathan, Vijay; Kornfeld, Hardy; Babu, Subash.
Afiliação
  • Kumar NP; National Institutes of Health-NIRT-International Center for Excellence in Research, Chennai, India.
  • Moideen K; National Institutes of Health-NIRT-International Center for Excellence in Research, Chennai, India.
  • Sivakumar S; National Institutes of Health-NIRT-International Center for Excellence in Research, Chennai, India.
  • Menon PA; National Institutes of Health-NIRT-International Center for Excellence in Research, Chennai, India.
  • Viswanathan V; Prof. M. Viswanathan Diabetes Research Center, Chennai, India.
  • Kornfeld H; University of Massachusetts Medical School, Worcester, MA, USA.
  • Babu S; National Institutes of Health-NIRT-International Center for Excellence in Research, Chennai, India; LPD, NIAID, NIH, MD, USA. Electronic address: sbabu@mail.nih.gov.
J Infect ; 74(1): 10-21, 2017 01.
Article em En | MEDLINE | ID: mdl-27717783

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tuberculose / Proteínas Angiogênicas / Complicações do Diabetes / Diabetes Mellitus Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Infect Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Índia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tuberculose / Proteínas Angiogênicas / Complicações do Diabetes / Diabetes Mellitus Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Infect Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Índia